Breaking News Instant updates and real-time market news.

AMAG

Amag Pharmaceuticals

$9.95

0.25 (2.58%)

07:18
11/04/19
11/04
07:18
11/04/19
07:18

Amag Pharmaceuticals price target lowered to $14 from $16 at Barclays

Barclays analyst Balaji Prasad lowered his price target for Amag Pharmaceuticals to $14 from $16 saying that apart from the script trends for Vyleesi, the positives "were limited" in the company's Q3. The analyst sees two broad scenarios following the FDA panel's split vote. Either the agency asks Makena to be withdrawn, which Amag will counter and it turns into a prolonged affair, or the FDA allows Makena to stay, and requests additional trials with associated cost implications, Prasad tells investors in a research note. The analyst, however, still has faith in the portfolio and keeps an Overweight rating on Amag Pharmaceuticals.

  • 07

    Dec

AMAG Amag Pharmaceuticals
$9.95

0.25 (2.58%)

10/25/19
PIPR
10/25/19
NO CHANGE
Target $9
PIPR
Neutral
Piper says briefing docs for Amag's Makena make arguments to pull and not pull
Piper Jaffray analyst Christoper Raymond said the briefing documents posted this morning ahead of Tuesday's advisory committee meeting to discuss Makena's failed confirmatory PROLONG trial "leave the door open" for the continued marketing of the drug. Draft questions propose pursuing withdrawal of Makena's approval, leaving Makena on the market but requiring a new confirmatory trial, or leaving it on the market without a new confirmatory trial and he thinks it appears that the FDA "is leaning toward the latter two options." However, he also thinks that the detailed PROLONG data that have now been provided for the first time "make a strong argument for the drug's withdrawal," Raymond tells investors. The analyst sees the full PROLONG data having "some chilling effect" on overall use whether the FDA pulls the drug or not and he keeps a Neutral rating on Amag Pharmaceuticals shares.
10/30/19
PIPR
10/30/19
DOWNGRADE
Target $6
PIPR
Underweight
Amag Pharmaceuticals downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst Christoper Raymond downgraded Amag Pharmaceuticals to Underweight from Neutral with a price target of $6, down from $9. The stock halted yesterday at $13.33. An FDA panel yesterday issued a "surprisingly definitive" vote to withdraw Makena's approval, Raymond tells investors in a research note. The analyst, who has long argued the totality of the data casts doubt on the clinical utility of Makena as an effective treatment for the prevention of preterm birth, assumed the FDA "could exercise flexibility if the AdCom was supportive." However, yesterday's vote provides the agency "all the cover it needs" to withdraw Makena approval. He says this, coupled with Amag's "non-trivial debt burden" and history of investing heavily in unsuccessful launches, makes it hard to justify "even a Neutral thesis."
10/30/19
10/30/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. GrubHub (GRUB) downgraded to Neutral from Buy at Goldman Sachs, BTIG, Mizuho, and DA Davidson, to Neutral from Outperform at Wedbush, to Market Perform from Outperform at JMP Securities and Cowen, and to Hold from Buy at Stifel. 2. Ingersoll-Rand (IR) downgraded to Hold from Buy at Deutsche Bank with analyst Nicole DeBlase saying much of the near-term merger-driven upside potential is now reflected in the share price. 3. Xerox (XRX) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster saying the stock, which is up 74% year-to-date, is trading close to peak forward multiples for the last two years. 4. Amag Pharmaceuticals (AMAG) downgraded to Underweight from Neutral at Piper Jaffray saying an FDA panel yesterday issued a "surprisingly definitive" vote to withdraw Makena's approval. 5. Werner (WERN) downgraded to Hold from Buy at Stifel with analyst David Ross citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/19
PIPR
11/01/19
NO CHANGE
Target $6
PIPR
Underweight
Amag comments on Makena don't 'square with reality,' says Piper Jaffray
Piper Jaffray analyst Christoper Raymond said he remains a seller of shares of Amag Pharmaceuticals and he keeps an Underweight rating on the stock after the company's Q3 revenue missed forecasts and it cut its FY19 outlook. The FDA is contemplating withdrawal of marketing approval for Makena, which a panel of advisors voted in favor of the agency doing, yet management continues to guide to 2020 as if the drug will remain on the market, which "doesn't square with reality," said Raymond. The analyst, who also cites Intrarosa's continued underperformance and his view that Vyleesi is "unlikely to move the needle," keeps a $6 price target on Amag shares.

TODAY'S FREE FLY STORIES

AEO

American Eagle

$15.23

-0.115 (-0.75%)

11:35
12/10/19
12/10
11:35
12/10/19
11:35
Options
American Eagle put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

11:35
12/10/19
12/10
11:35
12/10/19
11:35
General news
Treasury 10-year reopening: the auction should go well »

Treasury 10-year…

NFLX

Netflix

$297.65

-4.83 (-1.60%)

, CHD

Church & Dwight

$69.11

-1.22 (-1.73%)

11:34
12/10/19
12/10
11:34
12/10/19
11:34
On The Fly
Netflix, Church & Dwight downgrades among today's top analyst calls »

Check out today's top…

NFLX

Netflix

$297.65

-4.83 (-1.60%)

CHD

Church & Dwight

$69.11

-1.22 (-1.73%)

IP

International Paper

$46.46

-1 (-2.11%)

PKG

Packaging Corp.

$111.62

-1.935 (-1.70%)

VTR

Ventas

$56.30

-1.2 (-2.09%)

AAPL

Apple

$269.22

2.29 (0.86%)

QSR

Restaurant Brands

$66.95

0.95 (1.44%)

DPZ

Domino's Pizza

$285.31

-1.28 (-0.45%)

MCD

McDonald's

$194.76

0.05 (0.03%)

SBUX

Starbucks

$86.48

0.2 (0.23%)

WEN

Wendy's

$21.49

-0.23 (-1.06%)

CMG

Chipotle

$816.71

-10.85 (-1.31%)

DNKN

Dunkin' Brands

$75.88

-0.35 (-0.46%)

EAT

Brinker

$41.87

-0.82 (-1.92%)

YUM

Yum! Brands

$99.03

0.04 (0.04%)

TXRH

Texas Roadhouse

$56.23

0.08 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

  • 30

    Jan

HOME

At Home Group

$6.02

-0.31 (-4.90%)

11:25
12/10/19
12/10
11:25
12/10/19
11:25
Options
At Home Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
12/10/19
12/10
11:20
12/10/19
11:20
General news
Treasury announced $75 B in 4- and 8-week bill auctions for Thursday »

Treasury announced $75 B…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/10/19
12/10
11:17
12/10/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/10/19
12/10
11:16
12/10/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$89.86

-1.8 (-1.96%)

11:06
12/10/19
12/10
11:06
12/10/19
11:06
Hot Stocks
Michigan Township announces filing new lawsuit against Visteon »

Van Buren Charter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$194.55

-0.16 (-0.08%)

11:05
12/10/19
12/10
11:05
12/10/19
11:05
Hot Stocks
McDonald's names Ian Borden as president, International »

McDonald's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$5.70

0.09 (1.60%)

11:05
12/10/19
12/10
11:05
12/10/19
11:05
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$17.79

-0.04 (-0.22%)

11:02
12/10/19
12/10
11:02
12/10/19
11:02
Hot Stocks
Embraer signs order with Congo Airways for 2 E175 jets »

Embraer and Congo Airways…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$33.90

-0.875 (-2.52%)

, UBER

Uber

$27.89

0.18 (0.65%)

10:50
12/10/19
12/10
10:50
12/10/19
10:50
On The Fly
Analysts say controversial Peloton TV ad 'actually increases' brand awareness »

Pelton Interactive (PTON)…

PTON

Peloton

$33.90

-0.875 (-2.52%)

UBER

Uber

$27.89

0.18 (0.65%)

SDC

SmileDirectClub

$8.32

0.08 (0.97%)

LYFT

Lyft

$45.61

0.2 (0.44%)

WORK

Slack Technologies

$22.65

-0.34 (-1.48%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CONN

Conn's

$14.77

-5.74 (-27.99%)

10:45
12/10/19
12/10
10:45
12/10/19
10:45
Hot Stocks
Conn's says CECL adoption to lead to 40%-60% increase in provisions »

Conn's says the CECL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

VOD

Vodafone

$18.79

-0.085 (-0.45%)

10:45
12/10/19
12/10
10:45
12/10/19
10:45
Options
Vodafone call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/10/19
12/10
10:45
12/10/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

10:45
12/10/19
12/10
10:45
12/10/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

10:45
12/10/19
12/10
10:45
12/10/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

10:45
12/10/19
12/10
10:45
12/10/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

BPOP

Popular

$57.11

1.07 (1.91%)

10:43
12/10/19
12/10
10:43
12/10/19
10:43
Hot Stocks
Popular says Raging Capital letter shared with board, seeks 'open dialogue' »

Popular confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFL

GFL Environmental

$0.00

(0.00%)

10:41
12/10/19
12/10
10:41
12/10/19
10:41
Hot Stocks
GFL Environmental to acquire County Waste of Virginia; terms not disclosed »

GFL Environmental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$347.25

7.78 (2.29%)

10:38
12/10/19
12/10
10:38
12/10/19
10:38
Recommendations
Tesla analyst commentary  »

Tesla price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 07

    Jan

AXTA

Axalta Coating

$29.81

-0.41 (-1.36%)

10:35
12/10/19
12/10
10:35
12/10/19
10:35
Options
Axalta Coating put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
12/10/19
12/10
10:30
12/10/19
10:30
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

NLOK

NortonLifeLock

$26.29

0.86 (3.38%)

10:25
12/10/19
12/10
10:25
12/10/19
10:25
Options
NortonLifeLock call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

10:25
12/10/19
12/10
10:25
12/10/19
10:25
Conference/Events
UBS alternative energy windham to hold an analyst/industry conference call »

Alternative Energy &…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.